Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruconest for Delayed Graft Function in DCD Kidney Transplant
NCT03791476Phase 1Unknown
- Sponsor
- University of Wisconsin–Madison
- Start
- Jun 2019
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of c1-esterase inhibitor in delayed graft function (DGF), sponsored by University of Wisconsin–Madison. Primary endpoint: Incidence of Delayed Graft Function at 12 months. Status: unknown.
02
Drugs
c1-esterase inhibitor
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT03791476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791476.